CTRI/2014/09/005058已完成2 期
Clinical Evaluation of Vajraka Ghrita, Arogyavardhini Vati and Dineshavalyadi Taila in the Management of Kitibha (Psoriasis)
试验速览
- 阶段
- 2 期
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Known cases of psoriasis, without psoriatic arthropathy,
- •Exhibiting psoriatic triad â??
- •I.Bright pink or red lesions with pronounced edges, covered with silvery white scales, the scales can be easily separated from the lesion
- •II.Under the scales there appears a pinkish moist tender skin
- •III.With the scarping of the moist skin there appear tiny blood droplets (Auspitzâ??s sign)
- •2.Patients suffering from mild to moderate psoriasis with less than 50 % of the body surface involvement
- •3.Patients having less than 10 years duration
- •4.Positive histopathological finding.(Skin-biopsy - optional)
排除标准
- •1.Age below 18 years and above 60 years
- •2.Patients with other forms of Psoriasis like Guttate/ Pustular/ Erythrodermic/ inverse.
- •3.Patients suffering from severe psoriasis with more than 50% of the body surface involvement
- •4.Patients having chronic disease i.e. more than10 years duration
- •5.Patients who cannot report in person every 2 weeks in the OPD
- •6.Patients with Psoriatic arthropathy
- •7.Patients with poorly controlled Hypertension ( >160/100 mmHg)
- •8.Patients with poorly controlled Diabetes Mellitus having Hb A1C of > 7.5%
- •9.Patients on medication with corticosteroids, phototherapy, biologics, antidepressants any other drugs that may have an influence on the outcome of the study.
- •10.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •11.Symptomatic patient with clinical evidence of Heart failure.
- •12.Known HIV positive cases
- •13.Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), or any other condition that may jeopardize the study.
- •14.Alcoholics and/or drug abusers
- •15.H/o hypersensitivity to any of the trial drugs or their ingredients
- •16. Pregnant/lactating woman.
- •17.Patients who have completed participation in any other clinical trial during the past six months.
- •18.Any other condition which the Investigator thinks may jeopardize the study.
研究者
相似试验
尚未招募
2 期
se of VAJRAKA GHRITA in the management of EKAKUSTHACTRI/2024/07/071333Government Akhandanand Ayurved college
尚未招募
Unknown
study of vyoshadi gutika in vataja pratishyaya (allergic rhinitis)CTRI/2023/07/054777Rishikul Campus
进行中（未招募）
2 期
A clinical study to see the effect of some Ayurvedic formulations in the patients of Rheumatoid Arthritis.CTRI/2014/05/004629CCRAS240
已完成
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of Arthritis knee.CTRI/2014/02/004388Central Council for Research in Ayurvedic Sciences180
尚未招募
2 期
Effect of Guda-Haritaki(vardhamana krama) in the management of Yakritjanya jalodara with special reference to Ascites of Hepatic Cirrhosis origiCTRI/2024/07/070171Government Akhandanand Ayurveda College Ahmedabad